Literature DB >> 28979397

Pharmacokinetic considerations and dosing strategies of antibiotics in the critically ill patient.

Snehal Shah1, Greg Barton2, Andreas Fischer1.   

Abstract

The treatment of sepsis remains a significant challenge and is the cause of high mortality and morbidity. The pathophysiological alterations that are associated with sepsis can complicate drug dosing. Critical care patients often have capillary leak, increased cardiac output and altered protein levels which can have profound effects on the volume of distribution (Vd) and clearance (Cl) of antibacterial agents, both of which may affect the pharmacokinetics (PK) / pharmacodynamics (PD) of the drug. Along with antibacterial factors such as the hydrophilicity and its kill characteristics and the susceptibility and site of action of the microorganism, different dosing and administration strategies may be needed for the different drug classes. In conclusion, developing dosing and administration regimes of antibacterials that adhere to PK/PD principles increase antibacterial exposure. Tailoring therapy to the individual patient combined with TDM may contribute to improved clinical efficacy and contain the spread of resistance.

Entities:  

Keywords:  Antibiotics; beta lactams; critical care; pharmacokinetics; sepsis

Year:  2015        PMID: 28979397      PMCID: PMC5606477          DOI: 10.1177/1751143714564816

Source DB:  PubMed          Journal:  J Intensive Care Soc        ISSN: 1751-1437


  28 in total

1.  Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: special emphasis on unbound pharmacokinetics.

Authors:  Marta Ulldemolins; Jason A Roberts; Steven C Wallis; Jordi Rello; Jeffrey Lipman
Journal:  J Antimicrob Chemother       Date:  2010-06-08       Impact factor: 5.790

2.  Clinical cure of ventilator-associated pneumonia treated with piperacillin/tazobactam administered by continuous or intermittent infusion.

Authors:  Leonardo Lorente; Alejandro Jiménez; María M Martín; José Luis Iribarren; Juan José Jiménez; María L Mora
Journal:  Int J Antimicrob Agents       Date:  2009-01-15       Impact factor: 5.283

Review 3.  Effects of renal failure on drug transport and metabolism.

Authors:  Hong Sun; Lynda Frassetto; Leslie Z Benet
Journal:  Pharmacol Ther       Date:  2005-08-08       Impact factor: 12.310

Review 4.  Therapeutic intervention and targets for sepsis.

Authors:  Todd W Rice; Gordon R Bernard
Journal:  Annu Rev Med       Date:  2005       Impact factor: 13.739

5.  Ertapenem in critically ill patients with early-onset ventilator-associated pneumonia: pharmacokinetics with special consideration of free-drug concentration.

Authors:  Olaf Burkhardt; Vipul Kumar; Denise Katterwe; Jolanta Majcher-Peszynska; Bernd Drewelow; Hartmut Derendorf; Tobias Welte
Journal:  J Antimicrob Chemother       Date:  2006-12-21       Impact factor: 5.790

6.  Subtherapeutic initial β-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations.

Authors:  Andrew A Udy; Julie M Varghese; Mahdi Altukroni; Scott Briscoe; Brett C McWhinney; Jacobus P Ungerer; Jeffrey Lipman; Jason A Roberts
Journal:  Chest       Date:  2012-07       Impact factor: 9.410

7.  International study of the prevalence and outcomes of infection in intensive care units.

Authors:  Jean-Louis Vincent; Jordi Rello; John Marshall; Eliezer Silva; Antonio Anzueto; Claude D Martin; Rui Moreno; Jeffrey Lipman; Charles Gomersall; Yasser Sakr; Konrad Reinhart
Journal:  JAMA       Date:  2009-12-02       Impact factor: 56.272

8.  Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: a retrospective, nonrandomized, open-label, historical chart review.

Authors:  Leonardo Lorente; Alejandro Jiménez; Salome Palmero; Juan José Jiménez; José Luís Iribarren; Melitón Santana; María M Martín; Maria L Mora
Journal:  Clin Ther       Date:  2007-11       Impact factor: 3.393

9.  Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections.

Authors:  Peggy S McKinnon; Joseph A Paladino; Jerome J Schentag
Journal:  Int J Antimicrob Agents       Date:  2008-03-04       Impact factor: 5.283

10.  DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients?

Authors:  Jason A Roberts; Sanjoy K Paul; Murat Akova; Matteo Bassetti; Jan J De Waele; George Dimopoulos; Kirsi-Maija Kaukonen; Despoina Koulenti; Claude Martin; Philippe Montravers; Jordi Rello; Andrew Rhodes; Therese Starr; Steven C Wallis; Jeffrey Lipman
Journal:  Clin Infect Dis       Date:  2014-01-14       Impact factor: 9.079

View more
  11 in total

1.  Antibiotics in Adult Cystic Fibrosis Patients: A Review of Population Pharmacokinetic Analyses.

Authors:  Mehdi El Hassani; Jean-Alexandre Caissy; Amélie Marsot
Journal:  Clin Pharmacokinet       Date:  2021-01-15       Impact factor: 6.447

2.  Antivirulence Agent as an Adjuvant of β-Lactam Antibiotics in Treating Staphylococcal Infections.

Authors:  Peng Gao; Yuanxin Wei; Sherlock Shing Chiu Tai; Pradeep Halebeedu Prakash; Ho Ting Venice Iu; Yongli Li; Hin Cheung Bill Yam; Jonathan Hon Kwan Chen; Pak Leung Ho; Julian Davies; Richard Yi Tsun Kao
Journal:  Antibiotics (Basel)       Date:  2022-06-17

Review 3.  A Review: Antimicrobial Therapy for Human Pythiosis.

Authors:  Sadeep Medhasi; Ariya Chindamporn; Navaporn Worasilchai
Journal:  Antibiotics (Basel)       Date:  2022-03-26

4.  Comparison of Ceftriaxone and Antipseudomonal β-Lactam Antibiotics Utilized for Potential AmpC β-Lactamase-Producing Organisms.

Authors:  David M Peters; Jessica B Winter; Christopher A Droege; Neil E Ernst; Siyun Liao
Journal:  Hosp Pharm       Date:  2020-06-04

5.  A survey of antibiotic administration practices involving patients with sepsis in UK critical care units.

Authors:  Gregory J Barton; Charles W Morecroft; Neil C Henney
Journal:  Int J Clin Pharm       Date:  2019-11-14

Review 6.  The Minimum Inhibitory Concentration of Antibiotics: Methods, Interpretation, Clinical Relevance.

Authors:  Beata Kowalska-Krochmal; Ruth Dudek-Wicher
Journal:  Pathogens       Date:  2021-02-04

Review 7.  Post-Dialysis Parenteral Antimicrobial Therapy in Patients Receiving Intermittent High-Flux Hemodialysis.

Authors:  Christo Cimino; Yvonne Burnett; Nikunj Vyas; Anne H Norris
Journal:  Drugs       Date:  2021-02-16       Impact factor: 11.431

8.  Chronic wound isolates and their minimum inhibitory concentrations against third generation cephalosporins at a tertiary hospital in Uganda.

Authors:  Khalim Wangoye; James Mwesigye; Martin Tungotyo; Silvano Twinomujuni Samba
Journal:  Sci Rep       Date:  2022-01-24       Impact factor: 4.379

9.  Resistance pattern of infected chronic wound isolates and factors associated with bacterial resistance to third generation cephalosporins at Mbarara Regional Referral Hospital, Uganda.

Authors:  Wangoye Khalim; James Mwesigye; Martin Tungotyo; Silvano Samba Twinomujuni
Journal:  PLoS One       Date:  2021-12-16       Impact factor: 3.240

10.  The Synergistic Activity and Optimizing Doses of Tigecycline in Combination with Aminoglycosides against Clinical Carbapenem-Resistant Klebsiella pneumoniae Isolates.

Authors:  Parnrada Nulsopapon; Worapong Nasomsong; Manat Pongchaidecha; Dhitiwat Changpradub; Piraporn Juntanawiwat; Wichai Santimaleeworagun
Journal:  Antibiotics (Basel)       Date:  2021-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.